MedPath

Ethacrynic Acid

Ethacrynic Acid Tablets USP

Approved
Approval ID

de7c25a6-ed00-4ef3-883d-f8841f5dbd02

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 19, 2021

Manufacturers
FDA

Edenbridge Pharmaceuticals LLC.

DUNS: 948715060

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ethacrynic Acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42799-405
Application NumberANDA205609
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ethacrynic Acid
Product Specifications
Route of AdministrationORAL
Effective DateJuly 21, 2021
FDA Product Classification

INGREDIENTS (6)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
ETHACRYNIC ACIDActive
Quantity: 25 mg in 1 1
Code: M5DP350VZV
Classification: ACTIB
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ethacrynic Acid - FDA Drug Approval Details